Clonidine. A critical review of its role in the treatment of psychiatric disorders

CNS Drugs

Volumn 6, Issue 1, 1996, Pages 53-70

  Ahmed, Iqbal ^a   Takeshita, Junji ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE;

ANOREXIA NERVOSA; ANXIETY NEUROSIS; COGNITIVE DEFECT; DEPRESSION; HUMAN; MENTAL DISEASE; MOTOR DYSFUNCTION; NARCOLEPSY; NEUROTOXICITY; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SUBSTANCE ABUSE; XEROSTOMIA;

EID: 0029957859     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-199606010-00005     Document Type: Review

References (130)

1. Ahmed I. Use of cardiovascular drugs in clinical psychopharmacology. Hosp Formul 1991; 26: 364-78
2. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In: Gilman AG, Rall TW, Nies AS, et al. editors. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Pergammon Press, 1990: 187-243
3. Lowenthal DT, Matzek KM, MacGregor TR. Clinical pharmacokinetics of clonidine. Clin Pharmacokinet 1988; 14: 287-310
4. Houston MC. Clonidine hydrochloride: review of pharmacologic and clinical aspects. Prog Cardiovasc Dis 1981; 23: 337-50
5. Buccafusco JJ. Neuropharmacologic and behavioral actions of clonidine: interactions with central neurotransmitters. Int Rev Neurobiol 1992; 33: 55-107
6. Langer SZ. Presynaptic regulation of monoaminergic neurons. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987: 151-8
7. Kobinger W. Central alpha-adrenergic systems as targets for hypotensive drugs. Rev Physiol Biochem Pharmacol 1978; 81: 39-100
8. Hamilton CA, Yakubu MA, Howie CA, et al. Do centrally-acting antihypertensive drugs act at non-adrenergic as well as alpha-2 adrenoceptor sites? Clin Exp Hypertens 1992; A14 (5): 815-35
9. Sannajust F, Head GA. Involvement of imidazoline-preferring receptors in regulation of sympathetic tone. Am J Cardiol 1994; 74 (10): 7A-19A
10. Foote SL, Aston-Jones GS. Pharmacology and physiology of central noradrenergic systems. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 335-45
11. Svensson TH, Bunney BS, Aghajanian GK. Inhibition of both noradrenergic and serotonergic neurons in brain by alpha-adrenergic agonist clonidine. Brain Res 1975; 92: 291-306
12. Ghigo E, Bellone E, Arvat E, et al. Effects of alpha- and beta-adrenergic agonists and antagonists on growth hormone secretion in man. J Neuroendocrinol 1990; 2: 473-6
13. Pineda J, Ruiz-Ortega JA, Ugedo L, et al. The stimulatory effect of clonidine on locus coeruleus noradrenergic neurons through imidazoline receptors is modulated by excitatory amino acids. Ann NY Acad Sci 1995; 763: 501-5
14. Long TD, Kathol RG. Critical review of data supporting affective disorder caused by nonpsychotropic medication. Ann Clin Psychiatry 1993; 5: 259-70
15. Hossman V, Maling TJB, Hamilton CA, et al. Sedative and cardiovascular effects of clonidine and nitrazepam. Clin Pharmacol Ther 1980; 28: 167-75
16. Spiegel R, Devos JE. Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects. Br J Clin Pharmacol 1980; 10 Suppl.: 165S-8S
17. Autret A, Minz M, Beillevaire T, et al. Effects of clonidine on sleep patterns in man. Eur J Clin Pharmacol 1977; 12: 319-22
18. Carskadon MA, Cavallo A, Rosekind MR. Sleepiness and nap sleep following a morning dose of clonidine. Sleep 1989; 12: 338-44
19. Kostis JB, Rosen RC, Holzer BC, et al. CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology 1990; 102: 163-70
20. Danchin N, Genton P, Atlas P, et al. Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study. Int J Clin Pharmacol Ther 1995; 1: 52-5
21. Wing LMH, Reid JL, Davies DS, et al. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension. Eur J Clin Pharmacol 1977; 12: 463-9
22. Soderpalm B, Engel JA. Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors. Pharmacol Biochem Behav 1988; 30: 471-7
23. Paykel ES, Fleminger R, Watson JP. Psychiatric side effects of antihypertensive drugs other than reserpine. J Clin Psychopharmacol 1982; 2: 14-39
24. Kumara Chandran KS. ECG and clonidine [letter]. J Am Child Adolesc Psychiatry 1994; 33: 1351-2
25. Hunyor SN, Hansson L, Harrison TS, et al. Effects of clonidine withdrawal: possible mechanisms and suggestions for management. BMJ 1973; 2: 209-11
26. Hansson L, Hunyor SN, Julius S, et al. Blood pressure crisis following withdrawal of clonidine (Catapres, Cataptresan), with special reference to arterial and urinary catecholamines, and suggestions for management. Am Heart J 1973; 85: 605-10
27. Metz S, Klein C, Morton N. Rebound hypertension after discontinuation of transdermal clonidine therapy. Am J Med 1987; 82: 17-9
28. El-Mallakh RS. The use of clonidine in psychiatry. Resid Staff Physician 1992; 38: 29-34
29. Briant RH, Reid JL, Dollery CT. Interactions between clonidine and desipramine in man. BMJ 1973; 1: 522-3
30. Van Spanning HW, Van Zweiten PA. The interference of tricyclic antidepressants with the central hypotensive action of clonidine. Eur J Pharmacol 1973; 24: 402-4
31. Bond WS. Psychiatric indications for clonidine: the neuropharmacologic and clinical basis. J Clin Psychopharmacol 1986; 6 (2): 81-7
32. Jouvent R, Lecrubier Y, Puesh AJ, et al. Antimanic effect of clonidine. Am J Psychiatry 1980; 137: 1275-6
33. Giannini AJ, Loiselle RH, Price WA, et al. Comparison of antimanic efficacy of clonidine and verapamil. J Clin Pharmacol 1985; 25: 307-8
34. Giannini AJ, Pascarzi GA, Loiselle RH, et al. Comparison of clonidine and lithium in the treatment of mania. Am J Psychiatry 1986; 143: 1608-9
35. Hardy MC, Lecrubier Y, Widlocher D. Efficacy of clonidine in 24 patients with acute mania. Am J Psychiatry 1986; 143: 1450-3
36. Janicak MD, Sharma RP, Easton M, et al. A double-blind placebo-controlled trial of clonidine in the treatment of acute mania. Psychopharmacol Bull 1989; 25 (2): 243-5
37. Giannini AJ, Sullivan B, Sarachene J, et al. Clonidine in the treatment of premenstrual syndrome: a subgroup study. J Clin Psychiatry 1988; 49: 62-3
38. Zubenko GS, Cohen BM, Lipinski JF, et al. Clonidine in the treatment of mania and mixed bipolar disorder. Am J Psychiatry 1984; 141: 1617-8
39. Rausch JL, Weston S, Plouffe L. Role of psychotropic medication in the treatment of affective symptoms in premenstrual syndrome. Clin Obstet Gynecol 1992; 35 (3): 667-8
40. Lipsedge MS, Prothero W. Clonidine and clomipramine in obsessive-compulsive disorder. Am J Psychiatry 1987; 144: 965-6
41. Hollander E, Fay M, Liebowitz MR. Clonidine and clomipramine in obsessive-compulsive disorder. Am J Psychiatry 1988; 145: 388-9
42. Liebowitz MR, Fyer AJ, McGrath P, et al. Clonidine treatment of panic disorder. Psychopharmacol Bull 1981; 17 (3): 122-3
43. Hoehn-Saric R, Merchant AF, Keyser ML, et al. Effects of clonidine on anxiety disorders. Arch Gen Psychiatry 1981; 38: 1278-82
44. Ko GN, Elsworth JD, Roth RH, et al. Panic-induced elevation of plasma MHPG in phobic-anxious patients: effects of clonidine and imipramine. Arch Gen Psychiatry 1983; 40: 425-30
45. Uhde TW, Stein MB, Vittone BJ, et al. Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Arch Gen Psychiatry 1989; 46: 170-7
46. Kinzie JD, Leung P. Clonidine in Cambodian patients with posttraumatic stress disorder. J Nerv Ment Dis 1989; 177: 546-50
47. Carabine UA, Milligan KR, Moore JA. Adrenergic modulation of preoperative anxiety: a comparison of temazepam, clonidine and timolol. Anesth Analg 1991; 73: 633-7
48. Laurito CR, Baughman VL, Becker GL, et al. The effectiveness of oral clonidine as a sedative/anxiolytic and as a drug to blunt the hemodynamic responses to laryngoscopy. J Clin Anesth 1991; 3: 186-93
49. Charney DS, Heninger GR. Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatry 1986; 43: 1042-54
50. Puzantian T, Hart LL. Clonidine in panic disorder. Ann Pharmacother 1993; 27: 1351-2
51. Hansenne M, Pitchot W, Ansseau M. The clonidine test in posttraumatic stress disorder. Am J Psychiatry 1991; 148: 810-1
52. Goodman WK, Charney DS, Price LH, et al. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry 1986; 143: 900-3
53. Fyer AJ, Liebowitz MR, Gorman JM, et al. Effects of clonidine on alprazolam discontinuation in panic patients: a pilot study. J Clin Psychopharmacol 1988; 8 (2): 270-4
54. Björkqvist SE. Clonidine in alcohol withdrawal. Acta Psychiatr Scand 1975; 52: 256-63
55. Walinder J, Balldin J, Bokstrom K, et al. Clonidine suppression of the alcohol withdrawal syndrome. Drug Alcohol Depend 1981; 8: 345-8
56. Wilkins AJ, Jenkins WJ, Steiner JA. Efficacy of clonidine in treatment of alcohol withdrawal state. Psychopharmacology 1983; 81: 78-80
57. Baumgartner GR, Rowen RC. Clonidine vs. chlordiazepoxide in the management of acute withdrawal syndrome. Arch Intern Med 1987; 147: 1223-6
58. Robinson BJ, Robinson GM, Maling TJB, et al. Is clonidine useful in the treatment of alcohol withdrawal? Alcohol Clin Exper Res 1989; 13 (1): 95-8
59. Gold MS, Pottash AC, Sweeney DR, et al. Opiate withdrawal using clonidine. JAMA 1980; 243 (4): 343-6
60. Jasinski DR, Johnson RE, Kocher TR. Clonidine in morphine withdrawal: differential effects on signs and symptoms. Arch Gen Psychiatry 1985; 42: 1063-6
61. Charney DS, Heninger GR, Kleber HD. The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone. Am J Psychiatry 1986; 143: 831-7
62. Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. Br J Addict 1988; 83: 567-75
63. Franks P, Harp J, Bell B. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting. JAMA 1989; 262 (21): 3011-3
64. Glassman AH, Covey LS, Dalack GW, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Trials Ther 1993; 54 (6): 670-9
65. Keshavan MS, Crammer JL. Clonidine in benzodiazepine withdrawal. Lancet 1985; 1: 1325-6
66. Vinogradov S, Reiss AL, Csernansky JG. Clonidine therapy in withdrawal from high-dose alprazolam treatment [letter]. Am J Psychiatry 1986; 143: 1188
67. Rosenbloom A. Emerging treatment options in the alcohol withdrawal syndrome. J Clin Psychiatry 1988; 49 (12 Suppl.): 28-31
68. Cushman P. Clonidine and alcohol withdrawal. Adv Alcohol Subst Abuse 1987; 7: 17-28
69. Flemenbaum A, Boza R, Slater VL, et al. Clonidine opiate withdrawal. Resid Staff Physician 1989; 35: 10: 111-5
70. Kosten TR. Current pharmacotherapies for opioid dependence. Psychopharmacol Bull 1990; 26 (1): 69-74
71. Roerich H, Gold MS. Clonidine. Adv Alcohol Subst Abuse 1987; 7: 1-16
72. Chalil LA. The properties of the clonidine withdrawal response of guinea pig isolated ileum. Br J Pharmacol 1985; 85: 457-62
73. Hoder EL, Leckman JF, Poulsen J, et al. Clonidine treatment of neonatal narcotic abstinence syndrome. Psychiatry Res 1984; 13: 243-51
74. Raber JH, Shinar C, Finkelstein S. Clonidine patch ingestion in an adult. Ann Pharmacother 1993; 27: 719-22
75. Hughes PL, Morse RM. Use of clonidine in a mixed-drug detoxification regimen: possibility of masking of clinical signs of sedative withdrawal. Mayo Clin Proc 1985; 60: 47-9
76. Schaut J, Schnoll SH. Four cases of clonidine abuse. Am J Psychiatry 1983; 140: 1624-7
77. Gold MS. Opiate addiction and the locus ceruleus. The clinical utility of clonidine, naltrexone, methadone and buprenorphine. Psychiatr Clin North Am 1993; 16 (1): 61-73
78. Lucas LM. A trial of clonidine to stop smoking [letter]. JAMA 1990; 263 (20): 2746
79. Ghaziuddin M, Tsai L, Ghaziuddin N. Clonidine for autism [letter]. J Child Adolescent Psychopharmacol 1992; 2: 4
80. Jaskelskis CA, Cook EH, Fletcher KE, et al. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol 1992; 12 (6): 322-7
81. Koshes RJ, Rock NL. Use of clonidine for behavioral control in an adult patient with autism [letter]. Am J Psychiatry 1994; 151 (11): 1714
82. Schvehla TJ, Mandoki MW, Sumner GS. Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit. South Med J 1994; 87 (7): 692-5
83. Mandoki MW. Clonidine D-amphetamine combination in the treatment of children with attention deficit hyperactivity disorder [abstract]. Neuropsychopharmacology 1993; 9 (2 Suppl.): 183S
84. Leckman JF, Hardin MT, Riddle MA, et al. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1991; 48: 324-8
85. McKeith IG, Williams A, Nicol AR. Clonidine in Tourette syndrome. Lancet 1981; I: 270-1
86. Borison RL, Arg L, Hamilton WJ, et al. Treatment approaches in Gilles de la Tourette syndrome. Brain Res Bull 1983; 11: 205-8
87. Dysken MW, Berecy JM, Samarza A, et al. Clonidine in Tourette syndrome. Lancet 1981; II: 926-7
88. Goetz CG, Tanner CM, Wilson RS, et al. Clonidine and Gilles de la Tourette syndrome: double-blind study using objective rating methods. Ann Neurol 1987; 21: 307-10
89. Leckman JF, Ort S, Caruso KA, et al. Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Arch Gen Psychiatry 1986; 43: 1168-76
90. Dillon JE. Self-injurious behavior associated with clonidine withdrawal in a child with Tourette's disorder. J Child Neurol 1990; 5: 308-10
91. Shapiro E, Shapiro AK, Fulop G, et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989; 46: 722-30
92. Peterson BS. Natural history, pathophysiology, and treatment of Tourette's syndrome [monograph]. J Clin Psychiatry 1995; 13 (1): 17-9
93. . Arnsten AFT, Goldman-Rakic PS. Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged non-human primates. Science 1985; 230: 1273-6
94. Arnsten AFT, Cai JX, Goldman-Rakic PS. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 adrenergic subtypes. J Neurosci 1988; 8: 4287-98
95. Arnsten AFT, Conant TA. Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task. Psychopharmacology 1992; 108: 159-69
96. Davis HP, Callahan MJ, Downs DA. Clonidine disrupts aged monkey delayed response performance. Drug Dev Res 1988; 12: 279-80
97. Frith CD, Dowdy J, Ferrier IN, et al. Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine). Psychopharmacology 1985; 87: 490-3
98. Frith CD, McGinty MA, Gergel I, et al. The effects of scopolamine and clonidine upon the performance and learning of a motor skill. Psychopharmacology 1989; 98: 120-5
99. Clark CR, Geffen GM, Geffen LB. Catecholamines and the covert orienting of attention. Neuropsychologia 1986; 27: 131-40
100. McEntee WJ, Mair RG. Memory enhancement in Korsakoff's psychosis by clonidine: further evidence of a noradrenergic deficit. Ann Neurol 1980; 27: 466-70
101. Mair RG, McEntee WJ. Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-dopa and ephedrine. Psychopharmacology 1986; 88: 374-80
102. 99mTc-exametazine in anterior cingulate cortex in Korsakoff's psychosis. Psychol Med 1994; 24: 53-61
103. O'Carroll RE, Moffoot A, Ebmeier KP, et al. Korsakoff's syndrome, cognition and clonidine. Psychol Med 1993; 23: 341-7
104. Bierer LM, Aisen PS, Davidson M, et al. A pilot study of clonidine plus physostigmine in Alzheimer's disease. Dementia 1994; 5: 243-6
105. Fields RB, Van Kammen DP, Peters JL, et al. Clonidine improves memory function in schizophrenia independently from change in psychosis: preliminary findings. Schizophr Res 1988; 1: 417-23
106. Robbins TW, Everitt BJ. Central norepinephrine neurons and behavior. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 363-72
107. Coull JT. Pharmacological manipulations of the alpha 2-noradrenergic system: effects on cognition. Drugs Aging 1994; 5 (2): 116-26
108. Freedman R, Bell J, Kirch D. Clonidine therapy for coexisting psychosis and tardive dyskinesia. Am J Psychiatry 1980; 137: 629-30
109. Freedman R, Kirch D, Bell J, et al. Clonidine treatment of schizophrenia: double-blind comparison to placebo and neuroleptic drugs. Acta Psychiatr Scand 1982; 65: 35-45
110. Nishikawa T, Tanaka M, Koga I, et al. Clonidine therapy for tardive dyskinesia and related syndromes. Clin Neuropharmacol 1984; 7: 239-45
111. Tripodianakis J, Markianos M. Clonidine trial in tardive dyskinesia: MHPG and plasma DBH. Pharmacopsychiatry 1986; 19: 365-78
112. Browne J, Silver H, Martin R. The use of clonidine in the treatment of neuroleptic-induced tardive dyskinesia. J Clin Psychopharmacol 1986; 6: 88-92
113. Adityanjee, Singh S, Subramaniam M. Failure of clonidine in tardive dystonia: implications for nosology. Biol Psychiatry 1989; 26: 88-92
114. Zubenko GS, Cohen BM, Lipinski Jr JF, et al. Use of clonidine in treating neuroleptic-induced akathisia. Psychiatry Res 1984; 13: 253-9
115. Adler LA, Angrist B, Peselow E, et al. Clonidine in neuroleptic-induced akathisia. Am J Psychiatry 1987; 144: 235-6
116. Sachdev P, Chee K. Pharmacological characterization of tardive akathisia. Biol Psychiatry 1990; 28: 809-18
117. Handerwerker JV, Palmer RF. Clonidine in the treatment of restless legs syndrome. N Engl J Med 1985; 313: 1228-9
118. Steiner JC. Clonidine helps in restless legs syndrome [abstract]. Neurology 1987; 37 Suppl. 1: 278
119. Bastani B, Westervelt F. Effectiveness of clonidine in alleviating the symptoms of restless legs [letter]. Am J Kidney Dis 1987; 4: 326
120. Bamford CR, Sandyk R. Failure of clonidine to ameliorate the symptoms of restless legs syndrome. Sleep 1987; 10: 398-9
121. Ausserwinkler M, Schmidt P. Erfolgreiche Behandlung des (restless legs) - Syndrome bei chronischer Nierensuffizenz mit clonidin. Schweiz Med Wochenschr 1989; 119: 184-6
122. Zoe A, Wagner ML, Walters AS. High-dose clonidine in a case of restless legs syndrome. Ann Pharmacother 1994; 28: 878-81
123. Jeste DV, Wyatt RJ. Biochemical theories in understanding and treating tardive dyskinesia. New York: Guilford, 1982: 107-49
124. Putkonen PT, Bergstroen L. Inhibition of cataplectic attacks of narcolepsy by clonidine. Neurosci Lett 1979; 3 Suppl.: 5270
125. Salin-Pascual R, de la Fuente J-R, Fernandez-Guardola A. Effects of clonidine in narcolepsy. J Clin Psychiatry 1985; 46: 528-31
126. Casper RC, Schlemmer RF, Javaid JI. A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res 1987; 20: 249-60
127. Leeman CP. Pathophysiology of tricyclic-induced sweating. J Clin Psychiatry 1990; 51: 258-9
128. Feder R. Clonidine treatment of excessive sweating [letter]. J Clin Psychiatry 1995; 56: 35
129. Grabowski J. Clonidine treatment of clozapine-induced hypersalivation [letter]. J Clin Psychopharmacol 1992; 12 (1): 69-70
130. Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1945